Attention Deficit Hyperactivity Disorder
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-99
SponsorNantes University Hospital
About this trial
The ADA cohort aims for the systematic and standardized collection of sociodemographic, clinical and neuropsychological data, during 2 visits (inclusion and 12 months), from patients suffering from the co-occurrence of ADHD (Attention Deficit Hyperactivity Disorder) and addiction(s), in addition to the treatment as usual adapted to each situation.
Eligibility criteria
Qualifiers
Patients aged over 18 years
For whom a diagnosis of ADHD has been confirmed less than 12 weeks ago
For whom the diagnosis of one or more addictive disorder(s) (substance use disorder or behavioral addiction) has been confirmed
Meeting the indication for treatment with MPH according to European recommendations (Kooij et al., 2019)
Disqualifiers
Presenting disorders of higher cognitive functions (at the discretion of the referring clinician or the investigator making the inclusion), making data collection impossible
Presenting difficulties in reading or writing the French language making data collection impossible
Unable to commit to being available for the 2 visits planned as part of the cohort
Under guardianship or legal protection
Trial design
Treatments tested in this trial
- Patients suffering from the co-occurrence of ADHD and addiction(s)
Treatment groups
80 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov